Neuroscience News • 12/9/2025 – 12/14/2025

The U.S. Food and Drug Administration (FDA) has approved a device designed to treat depression through brain stimulation at home. This device operates by sending electric currents to a specific part of the brain that regulates mood, marking a significant advancement in mental health treatment. The approval allows patients to manage their condition outside of traditional clinical settings, potentially increasing accessibility to treatment for individuals suffering from depression. This innovation may lead to improved outcomes for patients who prefer to manage their treatment independently or who may not have access to conventional therapies. In addition to advancements in mental health technology, other scientific developments are occurring in various fields. For instance, William & Mary Biology Professor Jon Allen has discovered the world's oldest ribbon worm, named Baseodiscus the Eldest, in his lab. This finding adds to the list of significant scientific discoveries made by chance, highlighting the ongoing research efforts in biology and invertebrate studies. Meanwhile, the United States is facing challenges in its scientific research capabilities in Antarctica. The withdrawal of its last research ship is expected to hinder ongoing and future research efforts in the region, where the U.S. has historically conducted extensive studies. Scientists have expressed concerns that this decision may limit the U.S. ability to monitor climate change and its effects on polar regions, which are crucial indicators of global environmental shifts. The absence of a dedicated research vessel could also allow other nations to expand their influence in Antarctica, raising questions about the future of U.S. scientific leadership in polar research.
Advertisement



















